MRNA

#570
Moderna, Inc. Common Stock
54.03 USD
+2.25%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
53.61
54.16
Intervallo Annuale
22.29
59.55
Variazione giornaliera
+2.25%
Variazione Mensile
+1.18%
Variazione di 6 mesi
+93.73%
Variazione Annuale
+108.93%
Chiusura Precedente
52.84
Apertura
53.72
Bid
Ask
Minimo
53.61
High
54.16
Volume
668
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Moderna Inc

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.

Notizie